Progestogens Are Metabolized by the Gut Microbiota: Implications for Colonic Drug Delivery
- PMID: 32806503
- PMCID: PMC7464400
- DOI: 10.3390/pharmaceutics12080760
Progestogens Are Metabolized by the Gut Microbiota: Implications for Colonic Drug Delivery
Abstract
Following oral administration, the bioavailability of progestogens is very low and highly variable, in part due to metabolism by cytochrome P450 enzymes found in the mucosa of the small intestine. Conversely, the mucosa in the colon contains much lower levels of cytochrome P450 enzymes, thus, colonic delivery of progestogens may be beneficial. Microbiota in the colon are known to metabolize a great number of drugs, therefore, it is important to understand the stability of these hormones in the presence of colonic flora before developing formulations. The aim of this study was to investigate the stability of three progestogens: progesterone, and its two synthetic analogues, medroxyprogesterone acetate (MPA) and levonorgestrel (LNG), in the presence of human colonic microbiota. Progesterone, MPA, and LNG were incubated in mixed fecal inoculum (simulated human colonic fluid) under anerobic conditions. Progesterone was completely degraded after 2 h, whereas levels of MPA and LNG were still detectable after 24 h. The half-lives of progesterone, MPA, and LNG in fecal inoculum were 28, 644, and 240 min, respectively. This study describes the kinetics of colonic microbial metabolism of these hormones for the first time. MPA and LNG show promise for delivery to the colon, potentially improving pharmacokinetics over current oral delivery methods.
Keywords: colonic stability; gastrointestinal bacteria; large intestine metabolism; levonorgestrel; medroxyprogesterone; microbiome; progesterone; steroids.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures




Similar articles
-
Effects of progesterone, levonorgestrel and medroxyprogesterone acetate on apoptosis in human endometrial endothelial cells.Contraception. 2009 Feb;79(2):139-45. doi: 10.1016/j.contraception.2008.08.008. Epub 2008 Oct 9. Contraception. 2009. PMID: 19135572
-
Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.Gynecol Oncol. 2006 May;101(2):214-23. doi: 10.1016/j.ygyno.2005.10.030. Epub 2005 Dec 1. Gynecol Oncol. 2006. PMID: 16325240
-
Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms.J Steroid Biochem Mol Biol. 2019 May;189:145-153. doi: 10.1016/j.jsbmb.2019.02.010. Epub 2019 Feb 26. J Steroid Biochem Mol Biol. 2019. PMID: 30822501 Free PMC article.
-
Drug control of steroid metabolism by the hepatic endoplasmic reticulum.Drug Metab Rev. 1983;14(6):1119-44. doi: 10.3109/03602538308991424. Drug Metab Rev. 1983. PMID: 6373207 Review.
-
Levonorgestrel-Releasing Intrauterine Systems Versus Oral Cyclic Medroxyprogesterone Acetate in Endometrial Hyperplasia Therapy: A Meta-Analysis.Ann Surg Oncol. 2017 May;24(5):1322-1329. doi: 10.1245/s10434-016-5699-9. Epub 2016 Nov 28. Ann Surg Oncol. 2017. PMID: 27896507 Review.
Cited by
-
Sex, puberty, and the gut microbiome.Reproduction. 2023 Jan 4;165(2):R61-R74. doi: 10.1530/REP-22-0303. Print 2023 Feb 1. Reproduction. 2023. PMID: 36445259 Free PMC article. Review.
-
Harnessing machine learning for development of microbiome therapeutics.Gut Microbes. 2021 Jan-Dec;13(1):1-20. doi: 10.1080/19490976.2021.1872323. Gut Microbes. 2021. PMID: 33522391 Free PMC article.
-
Gut Microbiota in Women with Eating Disorders: A New Frontier in Pathophysiology and Treatment.Nutrients. 2025 Jul 14;17(14):2316. doi: 10.3390/nu17142316. Nutrients. 2025. PMID: 40732941 Free PMC article. Review.
-
Ileocolonic-Targeted JAK Inhibitor: A Safer and More Effective Treatment for Inflammatory Bowel Disease.Pharmaceutics. 2022 Nov 5;14(11):2385. doi: 10.3390/pharmaceutics14112385. Pharmaceutics. 2022. PMID: 36365202 Free PMC article.
-
Hormonal Environment Shapes the Oral Microbiome.Adv Exp Med Biol. 2025;1472:225-242. doi: 10.1007/978-3-031-79146-8_14. Adv Exp Med Biol. 2025. PMID: 40111695 Review.
References
-
- Sato T., Miyagawa S., Iguchi T. Subchapter 94A—Progesterone. In: Takei Y., Ando H., Tsutsui K., editors. Handbook of Hormones. Academic Press; San Diego, NY, USA: 2016. pp. 507–508.
-
- Schumacher M., Zhu X., Guennoun R. 3.11—Progesterone: Synthesis, Metabolism, Mechanism of Action, and Effects in the Nervous System. In: Pfaff D.W., Joëls M., editors. Hormones, Brain and Behavior. 3rd ed. Academic Press; Oxford, UK: 2017. pp. 215–244. - DOI
-
- National Institute for Health and Care Excellence (NICE) British National Formulary (BNF) NICE; London, UK: 2020. Progesterone.
-
- BesinsHealthcare . Electronic Medicines Compendium. EMC; London, UK: 2019. Utrogestan 100mg Capsules Summary of Product Characteristics.
-
- Bayer . Electronic Medicines Compendium. EMC; Leverkusen, Germany: 2019. Levonelle 1500 Microgram Tablet Summary of Product Characteristics.
LinkOut - more resources
Full Text Sources
Other Literature Sources